miRNAs-dependent alterations of PPARα signaling are reported by numerous studies to contribute to the onset of liver diseases such as nonalcoholic fatty liver disease (NAFLD) [19, 21, 29], chronic diseases associated with viral infections (HBV, HCV) [70], or hepatic cancers [30, 71]. Here, PPARA is linked to liver cancer.